Intensive weekly chemotherapy for the treatment of extensive-stage small-cell lung cancer

Journal of Clinical Oncology

Volumn 9, Issue 9, 1991, Pages 1632-1638

  Murray, Nevin ^a   Shah, Amil ^b   Osoba, David ^b   Page, Ruth ^b   Karsai, Helen ^b   Grafton, Clive ^b   Goddard, Karen ^b   Fairey, Randall ^b   Voss, Nicholas ^b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTINEOPLASTIC AGENT; CIMETIDINE; CISPLATIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; KETOCONAZOLE; NABILONE; PREDNISONE; PROCHLORPERAZINE; VINCRISTINE;

ADULT; ARTICLE; BONE MARROW SUPPRESSION; BRAIN METASTASIS; CLINICAL ARTICLE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG SMALL CELL CANCER; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SURVIVAL; TOXICITY;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; CISPLATIN; COMPARATIVE STUDY; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGE; PILOT PROJECTS; SURVIVAL RATE; VINCRISTINE;

EID: 0025864045     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1991.9.9.1632     Document Type: Article

References (31)

1. Bunn PA Jr, Cullen M, Fukuoka M, et al: Chemotherapy in small cell lung cancer: A consensus report. Lung Cancer 5:127-134, 1989
2. Seifter EJ, Ihde DC: Therapy of small cell lung cancer: A perspective on two decades of clinical research. Semin Oncol 15:278-299, 1988
3. Goldie JH, Coldman AJ: The genetic origin of drug resistance in neoplasms: Implications for systemic therapy. Cancer Res 44:3643-3653, 1984
4. Goldie JH, Coldman AJ, Gudauskas GA: Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treat Rep 66:439-449,1982
5. Cohen MH, Ihde DC, Bunn PA, et al: Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma. Cancer Treat Rep 63:163-170, 1979
6. Aisner J, Whitacre M, VanEcho DA, et al: Combination chemotherapy for small cell carcinoma of the lung: Continuous v alternating non-cross-resistant combinations. Cancer Treat Rep 66:221-230, 1982
7. Daniels JR, Chak LY, Sikic BI, et al: Chemotherapy of small cell carcinoma of the lung: A randomized comparison of alternating and sequential combination chemotherapy programs. J Clin Oncol 2:1192-1199, 1984
8. Markman M, Abeloff MD, Berkman AW, et al: Intensive alternating chemotherapy regimen in small cell carcinoma of the lung. Cancer Treat Rep 69:161-166, 1985
9. Murray N, Shah A, Wilson K, et al: Cyclic alternating chemotherapy for small cell carcinoma of the lung. Cancer Treat Rep 69:1241-1242, 1985
10. Ettinger DS, Mehta CR, Abeloff MD, et al: A randomized comparison of conventional chemotherapy with immediate alternation of non-cross-resistant chemotherapy in extensive disease (ED) small cell lung cancer (SCLC). Proc Am Soc Clin Oncol 5:170, 1986 (abstr)
11. Natale RB, Shank B, Hilaris B, et al: Combination cyclophosphamide, Adriamycin and vincristine rapidly alternating with combination cisplatin and VP-16 in treatment of small cell lung cancer. Am J Med 79:303-308, 1985
12. Evans WK, Feld R, Murray N, et al: Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. Ann Intern Med 107:451-458, 1987
13. Roth BJ, Johnson DH, Greco FA, et al: A phase III trial of etoposide (E) and cisplatin (P) versus cyclophosphamide (C), doxorubicin (A) and vincristine (V) versus alternation of the two therapies for patients with extensive small cell lung cancer: Preliminary results. Proc Am Soc Clin Oncol 8:225, 1989 (abstr)
14. Klimo P, Connors JM: MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. Ann Intern Med 102:596-602, 1985
15. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
16. Stewart DJ, Nundy D, Maroun JA, et al: Bioavailability, pharmacokinetics and clinical effects of an oral preparation of etoposide. Cancer Treat Rep 69:269-273, 1985
17. Miller AB, Hoogstraten B, Staquet M, et al: Reporting results of cancer treatment. Cancer 47:207-214, 1981
18. Strum WB: Prevention of duodenal ulcer recurrence. Ann Intern Med 105:757-761, 1986
19. Murray N, Shah A, Brown E, et al: Alternating chemotherapy and thoracic radiotherapy with concurrent cisplatin-etoposide for limited stage small cell carcinoma of the lung. Semin Oncol 13:24-30, 1986 (suppl 3)
20. Souhami RL, Finn G, Gregory WM, et al: High dose cyclophosphamide in small cell carcinoma of the lung. J Clin Oncol 3:958-963,1985
21. Johnson DH, DeLeo MJ, Hande KR, et al: High-dose induction chemotherapy with cyclophosphamide, etoposide, and cisplatin for extensive-stage small-cell lung cancer. J Clin Oncol 5:703-709, 1987
22. Schabel FM, Trader MW, Laster WK, et al: Cisdichlorodiammineplatinum (II): Combination chemotherapy and cross-resistance studies with tumors of mice. Cancer Treat Rep 63:1459-1473, 1979
23. Durand RE, Goldie JH: Interaction of etoposide and cisplatin in an in vitro tumour model. Cancer Treat Rep 71:673-679, 1987
24. Sierocki JS, Hilaris BS, Hopfan S, et al: cis-Dichlorodiammineplatinum (II) and VP-16-213: An active induction regimen for small cell carcinoma of the lung. Cancer Treat Rep 63:1593-1597, 1979
25. Evans WK, Osoba D, Feld R, et al: Etoposide (VP-16) and cisplatin: An effective treatment for relapse in small cell lung cancer. J Clin Oncol 3:65-71, 1985
26. Murray N: The importance of dose and dose intensity in lung cancer chemotherapy. Semin Oncol 14:20-28, 1987 (suppl 4)
27. Lee JS, Umsawasdi T, Dhingra HM, et al: Effects of brain irradiation and chemotherapy on myelosuppression in small-cell lung cancer. J Clin Oncol 4:1615-1619, 1986
28. Murray N, Osoba D, Shah A, et al: Brief intensive chemotherapy for metastatic nonsmall-cell lung cancer: A phase II study of the weekly CODE regimen. J Natl Cancer Inst 83:190-194, 1991
29. Tormey DC, Gelman R, Band PR, et al: Comparison of induction chemotherapies for metastatic breast cancer. Cancer 50:1235-1244, 1982
30. Figueredo AT, Hryniuk WM, Strautmanis I, et al: Cotrimoxazole prophylaxis during high-dose chemotherapy of small cell lung cancer. J Clin Oncol 3:54-64, 1985
31. Komaki R, Cox JD, Whitson W: Risk of brain metastasis from small cell carcinoma of the lung related to length of survival and prophylactic irradiation. Cancer Treat Rep 65:811-814, 1981